THURSDAY, Sept. 30, 2021 (HealthDay News) — Someday, your smartwatch might be able to tell you if you’re coming down with a virus and how sick you’ll be — even before symptoms start. In a small study, researchers showed that a wearable device, like a Fitbit or Apple Watch, couldContinue Reading
THURSDAY, Sept. 30, 2021 (HealthDay News) — Artificial intelligence (AI) might be able to spot the next virus to jump from animals to humans, Scottish researchers report. Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses canContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Pregnant women who receive an epidural to ease their pain during labor aren’t any more likely than others to have kids with autism, two new studies show. Earlier research suggested this practice may increase autism risk in offspring, but the pair of studiesContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A pair of experimental tests could help doctors detect colon or prostate cancer with just a sample of blood or saliva. One test examines a person’s blood for four biomarkers linked to inflammation. In a small study, it outperformed the fecal blood testContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A pair of experimental tests could help doctors detect colon or prostate cancer with just a sample of blood or saliva. One test examines a person’s blood for four biomarkers linked to inflammation. In a small study, it outperformed the fecal blood testContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A pair of experimental tests could help doctors detect colon or prostate cancer with just a sample of blood or saliva. One test examines a person’s blood for four biomarkers linked to inflammation. In a small study, it outperformed the fecal blood testContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Roughly a third of Americans on high blood pressure medications do not have their blood pressure under control, a new study reveals. And younger men and older women are particularly vulnerable, researchers warn. “Although this phenomenon has been hinted at in the medicalContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Roughly a third of Americans on high blood pressure medications do not have their blood pressure under control, a new study reveals. And younger men and older women are particularly vulnerable, researchers warn. “Although this phenomenon has been hinted at in the medicalContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Roughly a third of Americans on high blood pressure medications do not have their blood pressure under control, a new study reveals. And younger men and older women are particularly vulnerable, researchers warn. “Although this phenomenon has been hinted at in the medicalContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Spend time with babies and you’ll see they pick up items, bang them together and, often, chew on them. That play is key to learning and development, but most research on infant play has taken place in a lab and not on aContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Spend time with babies and you’ll see they pick up items, bang them together and, often, chew on them. That play is key to learning and development, but most research on infant play has taken place in a lab and not on aContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Spend time with babies and you’ll see they pick up items, bang them together and, often, chew on them. That play is key to learning and development, but most research on infant play has taken place in a lab and not on aContinue Reading
TUESDAY, Sept. 28, 2021 (HealthDay News) — A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests. Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person’s risk of type 2 diabetes by more than half,Continue Reading